Medicines and Healthcare products Regulatory Agency
| 1: Authorisation Number | UK MIA 45803 | 
|---|---|
| 2: Name of authorisation holder | ROSLIN CELL THERAPIES LIMITED | 
| 3: Address(es) of manufacturing site(s) | ROSLINCT - SHAWFAIR, 2 WESTER SHAWFAIR, DANDERHALL, DALKEITH, EH22 1FD, UNITED KINGDOM ROSLINCT- BIOCUBE 2 , BIOCUBE 2, 11 LITTLE FRANCE ROAD, EDINBURGH BIOQUARTER, EDINBURGH, EH16 4UX, UNITED KINGDOM | 
| 4: Legally registered address of authorisation holder | ROSLIN CELL THERAPIES LIMITED, 9 LITTLE FRANCE ROAD, EDINBURGH BIOQUARTER, EDINBURGH, EH16 4UX, UNITED KINGDOM | 
| 5: Scope of authorisation and dosage forms | ANNEX 1 and/ or ANNEX 2 | 
| 6: Legal Basis of authorisation | |
| 7: Name of responsible officer of the competent authority of the member state granting the manufacturing authorisation | Confidential | 
| 8: Authorisation Date | 19/06/2025 | 
| 9: Annexes attached | Annex 1 and/or Annex 2 | 
SCOPE OF AUTHORISATION
        Annex 1
        
          Name and address of the site: 
          
      
              
          
  
        
        
        ROSLINCT - SHAWFAIR, 2 WESTER SHAWFAIR, DANDERHALL, DALKEITH, EH22 1FD, UNITED KINGDOM
                                Human Medicinal Products
                            
      | Authorised Operations | 
| MANUFACTURING OPERATIONS (according to part 1) | 
| Part 1 - MANUFACTURING OPERATIONS | 
| [ 1.1 ] Sterile Products | 
| [ 1.1.3 ] Batch certification | 
| [ 1.3 ] Biological medicinal products | 
| [ 1.3.2 ] Batch certification | 
| [ 1.3.2.3 ] Cell therapy products Special Requirements Live Cells | 
| [ 1.3.2.4 ] Gene therapy products Special Requirements Live Cells | 
| [ 1.3.2.6 ] Human or animal extracted products Special Requirements Live Cells | 
SCOPE OF AUTHORISATION
        Annex 1
        
          Name and address of the site: 
          
      
              
          
  
        
        
        ROSLINCT- BIOCUBE 2 , BIOCUBE 2, 11 LITTLE FRANCE ROAD, EDINBURGH BIOQUARTER, EDINBURGH, EH16 4UX, UNITED KINGDOM
                                Human Medicinal Products
                            
      | Authorised Operations | 
| MANUFACTURING OPERATIONS (according to part 1) | 
| Part 1 - MANUFACTURING OPERATIONS | 
| [ 1.1 ] Sterile Products | 
| [ 1.1.1 ] Aseptically prepared (processing operations for the following dosage forms) | 
| [ 1.1.1.6 ] Other aseptically prepared products Cellular therapy products ( ATMPs), Master cell banks Special Requirements Live Cells | 
| [ 1.1.3 ] Batch certification | 
| [ 1.3 ] Biological medicinal products | 
| [ 1.3.1 ] Biological medicinal products | 
| [ 1.3.1.3 ] Cell therapy products Special Requirements Live Cells | 
| [ 1.3.1.4 ] Gene therapy products Special Requirements Live Cells | 
| [ 1.3.1.6 ] Human or animal extracted products Special Requirements Live Cells | 
| [ 1.3.1.7 ] Tissue Engineered Products Special Requirements Live Cells | 
| [ 1.3.2 ] Batch certification | 
| [ 1.3.2.3 ] Cell therapy products Special Requirements Live Cells | 
| [ 1.3.2.4 ] Gene therapy products Special Requirements Live Cells | 
| [ 1.3.2.6 ] Human or animal extracted products Special Requirements Live Cells | 
| [ 1.3.2.7 ] Tissue Engineered Products Special Requirements Live Cells | 
| [ 1.5 ] Packaging | 
| [ 1.5.1 ] Primary packaging | 
| [ 1.5.1.6 ] Liquids for internal use | 
| [ 1.5.2 ] Secondary packaging | 
